Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 6/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.46 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9403409 | 0.96 | CHRM5 (0.48) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL12560592 | 0.96 | CHRM5 (0.43) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Iodide SCHEMBL30166462 | 0.93 | CHRM5 (0.42) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Hydrochloric Acid SCHEMBL28136226 | 0.93 | CHRM5 (0.42) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL372664 | 0.87 | PRKD3 (0.44) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL1674935 | 0.85 | TSHR (0.56) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Fluoroethylcholine SCHEMBL1149413 | 0.85 | CHRM5 (0.37) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL3696755 | 0.85 | ACHE (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL3686618 | 0.85 | CHRM5 (0.37) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL12936646 | 0.85 | PRKD3 (0.42) | CHRM5CHRM1CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230236204-A1 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST (GB) | 2023-07-27 | — | — | US | disclosed |
| EP-3419753-B1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | VANDERBILT CHEMICALS LLC (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-4127728-A1 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | King's College Hospital NHS Foundation Trust (GB) | 2023-02-08 | — | — | EP | disclosed |
| CN-115335705-A | Non-invasive method for diagnosing liver fibrosis | 国王学院医院NHS信托基金会 | 2022-11-11 | — | — | CN | disclosed |
| WO-2021191603-A1 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST (GB) | 2021-09-30 | — | — | WO | disclosed |
| US-10590364-B2 | Quaternary ammonium sulfur-containing binuclear molybdate salts as lubricant additives | VANDERBILT CHEMICALS, LLC (US) | 2020-03-17 | — | — | US | disclosed |
| WO-2019048423-A1 | L-SERINE SUPPLEMENTATION IN SUBJECTS WITH PRE-DIABETES | RIGSHOSPITALET (DK) | 2019-03-14 | — | — | WO | disclosed |
| EP-3419753-A1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | Vanderbilt Chemicals, LLC (US) | 2019-01-02 | — | — | EP | disclosed |
| US-20180327685-A1 | Quaternary Ammonium Sulfur-Containing Binuclear Molybdate Salts as Lubricant Additives | VANDERBILT CHEMICALS LLC (US) | 2018-11-15 | — | — | US | disclosed |
| US-10059901-B2 | Quaternary ammonium sulfur-containing binuclear molybdate salts as lubricant additives | VANDERBILT CHEMICALS, LLC (US) | 2018-08-28 | — | — | US | disclosed |
| EP-1290034-B1 | A NEW TYPE OF CATIONIC STARCH PRODUCT, PREPARATION THEREOF AND ITS USE | RAISIO CHEM LTD (FI) | 2004-03-31 | — | — | EP | disclosed |
| EP-0928809-B1 | POLYSACCHARIDE DERIVATIVE/MAGNETIC METAL OXIDE COMPOSITE | MEITO SANGYO KK (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-20030177915-A1 | Type of cationic starch product, preparation thereof and its use | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-25 | — | — | US | disclosed |
| EP-1290034-A2 | A NEW TYPE OF CATIONIC STARCH PRODUCT, PREPARATION THEREOF AND ITS USE | Raisio Chemicals Ltd. (FI) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001090199-A2 | A NEW TYPE OF CATIONIC STARCH PRODUCT, PREPARATION THEREOF AND ITS USE | RAISIO CHEMICALS LTD (FI) | 2001-11-29 | — | — | WO | disclosed |
| US-6165378-A | Polysaccharide derivative/magnetic metal oxide composite | MEITO SANGYO KABUSHIKI KAISHA (JP) | 2000-12-26 | — | — | US | disclosed |
| EP-0928809-A1 | POLYSACCHARIDE DERIVATIVE/MAGNETIC METAL OXIDE COMPOSITE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1999-07-14 | — | — | EP | disclosed |
| US-4340698-A | CHOLINE COMPOUND CATALYST | INTERNATIONALE OCTROOI MAATSCHAPPIJ "OCTROPA" B.V. (NL) | 1982-07-20 | — | — | US | disclosed |
| EP-0010805-B1 | POWDER COATING, PROCESS FOR THE PREPARATION THEREOF AND ARTICLES COATED THEREWITH | UNILEVER N.V. (NL) | 1982-02-10 | — | — | EP | disclosed |
| EP-0010805-A1 | Powder coating, process for the preparation thereof and articles coated therewith | UNILEVER N.V. (NL) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590364-B2 | Quaternary ammonium sulfur-containing binuclear molybdate salts as lubricant additives | ATXN10, MDM4, OR10J3 | CHRM5 186/4885CHRM1 119/4885CHRM3 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.